DK1019058T3 - Farmaceutisk suspension omfattende hemihydratet af nevirapin - Google Patents

Farmaceutisk suspension omfattende hemihydratet af nevirapin

Info

Publication number
DK1019058T3
DK1019058T3 DK98939312T DK98939312T DK1019058T3 DK 1019058 T3 DK1019058 T3 DK 1019058T3 DK 98939312 T DK98939312 T DK 98939312T DK 98939312 T DK98939312 T DK 98939312T DK 1019058 T3 DK1019058 T3 DK 1019058T3
Authority
DK
Denmark
Prior art keywords
nevirapine
hemihydrate
pharmaceutical suspension
pharmaceutical
suspension
Prior art date
Application number
DK98939312T
Other languages
Danish (da)
English (en)
Inventor
Karl Georg Grozinger
Amale A Hawi
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1019058(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1019058T3 publication Critical patent/DK1019058T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98939312T 1997-08-25 1998-08-11 Farmaceutisk suspension omfattende hemihydratet af nevirapin DK1019058T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25

Publications (1)

Publication Number Publication Date
DK1019058T3 true DK1019058T3 (da) 2006-06-12

Family

ID=22006658

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98939312T DK1019058T3 (da) 1997-08-25 1998-08-11 Farmaceutisk suspension omfattende hemihydratet af nevirapin

Country Status (38)

Country Link
US (2) US6172059B1 (ru)
EP (1) EP1019058B1 (ru)
JP (1) JP3472261B2 (ru)
KR (1) KR100426516B1 (ru)
CN (1) CN1197578C (ru)
AR (2) AR016869A1 (ru)
AT (1) ATE326971T1 (ru)
AU (1) AU742761B2 (ru)
BG (1) BG64337B1 (ru)
BR (1) BR9811994B1 (ru)
CA (1) CA2301646C (ru)
CL (1) CL2008003111A1 (ru)
CO (1) CO4970742A1 (ru)
CY (1) CY1105228T1 (ru)
CZ (1) CZ290667B6 (ru)
DE (1) DE69834655T2 (ru)
DK (1) DK1019058T3 (ru)
EG (1) EG24075A (ru)
ES (1) ES2265666T3 (ru)
HK (1) HK1027975A1 (ru)
HR (1) HRP980461B1 (ru)
HU (1) HU226063B1 (ru)
ID (1) ID21650A (ru)
IL (1) IL134185A (ru)
MY (1) MY122272A (ru)
NO (1) NO326226B1 (ru)
NZ (1) NZ503414A (ru)
PE (1) PE105799A1 (ru)
PL (1) PL192361B1 (ru)
PT (1) PT1019058E (ru)
RS (1) RS49808B (ru)
RU (1) RU2196584C2 (ru)
SA (1) SA98190680B1 (ru)
TR (1) TR200000490T2 (ru)
TW (1) TW450812B (ru)
UA (1) UA44370C2 (ru)
WO (1) WO1999009990A1 (ru)
ZA (1) ZA987623B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
JP2005523951A (ja) * 2002-04-23 2005-08-11 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド カルボマー中の残留有機溶媒の低減方法
WO2007026156A1 (en) * 2005-08-31 2007-03-08 Cipla Limited Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
EP2306980A2 (en) * 2008-06-30 2011-04-13 Tibotec Pharmaceuticals Powders for reconstitution
CA2781014C (en) * 2009-11-10 2018-07-31 Wilna Liebenberg Method for increasing the solubility of a transcriptase inhibitor composition
WO2011073907A1 (en) * 2009-12-17 2011-06-23 North-West University A polymorph form of nevirapine and its preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)

Also Published As

Publication number Publication date
EP1019058A4 (en) 2004-11-10
NZ503414A (en) 2002-11-26
KR100426516B1 (ko) 2004-04-13
AU742761B2 (en) 2002-01-10
ES2265666T3 (es) 2007-02-16
IL134185A0 (en) 2001-04-30
YU9800A (sh) 2001-12-26
ID21650A (id) 1999-07-08
ZA987623B (en) 2000-03-22
AU8777198A (en) 1999-03-16
JP2001513564A (ja) 2001-09-04
EP1019058B1 (en) 2006-05-24
ATE326971T1 (de) 2006-06-15
PE105799A1 (es) 1999-11-16
CO4970742A1 (es) 2000-11-07
BG104133A (en) 2000-08-31
NO20000906L (no) 2000-02-24
EG24075A (en) 2008-05-11
BR9811994B1 (pt) 2013-11-19
DE69834655T2 (de) 2006-12-14
JP3472261B2 (ja) 2003-12-02
MY122272A (en) 2006-04-29
CZ290667B6 (cs) 2002-09-11
DE69834655D1 (de) 2006-06-29
US6172059B1 (en) 2001-01-09
HU226063B1 (hu) 2008-04-28
HRP980461B1 (en) 2002-08-31
WO1999009990A1 (en) 1999-03-04
CN1268055A (zh) 2000-09-27
NO20000906D0 (no) 2000-02-24
US6255481B1 (en) 2001-07-03
RU2196584C2 (ru) 2003-01-20
CL2008003111A1 (es) 2009-09-11
PL338828A1 (en) 2000-11-20
EP1019058A1 (en) 2000-07-19
RS49808B (sr) 2008-08-07
HK1027975A1 (en) 2001-02-02
PT1019058E (pt) 2006-08-31
AR083451A2 (es) 2013-02-27
NO326226B1 (no) 2008-10-20
SA98190680B1 (ar) 2006-04-04
IL134185A (en) 2005-11-20
CY1105228T1 (el) 2010-03-03
CA2301646C (en) 2008-11-18
CA2301646A1 (en) 1999-03-04
HRP980461A2 (en) 1999-06-30
UA44370C2 (uk) 2002-02-15
KR20010023257A (ko) 2001-03-26
CZ2000694A3 (cs) 2000-09-13
TR200000490T2 (tr) 2000-08-21
AR016869A1 (es) 2001-08-01
TW450812B (en) 2001-08-21
HUP0003093A2 (hu) 2001-08-28
BR9811994A (pt) 2000-09-05
PL192361B1 (pl) 2006-10-31
CN1197578C (zh) 2005-04-20
BG64337B1 (bg) 2004-10-29

Similar Documents

Publication Publication Date Title
IS5245A (is) Lyfjablanda úr ómeprasól
ID30262A (id) Ligan reseptor melanokortin
IS2142B (is) Nýtt form S-ómeprasóls
ID23874A (id) Obat
DE69825526D1 (de) Korrektur der vorgegebenen Zeit
EE03801B1 (xx) Stent
ID24458A (id) Modifikasi rheologi in-sito poliolefin
DE69831377D1 (de) Schutzbalg
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
ID29294A (id) Komposisi farmasi
PT964867E (pt) Antagonistas da taquicinima
DK1019058T3 (da) Farmaceutisk suspension omfattende hemihydratet af nevirapin
ID25857A (id) Komposisi farmasi
FR2767673B1 (fr) Prothese uretrale
DK1001962T3 (da) Fremstilling af avermectinforbindelser
DE59803628D1 (de) Modulare brücke
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK0855379T3 (da) Fremgangsmåde til fremstilling af benzophenonderivater
ATE232199T1 (de) Polymorphe modifikationen von dofetilid
DK0927163T3 (da) Fremstilling af 1-butyl-4-piperidinylmethylamin
DK0882722T3 (da) Fremstilling af alpha-tocopherol
IT243540Y1 (it) Pontile sospeso
ID23531A (id) Komposisi farmasi
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
DK1051401T3 (da) Fremgangsmåde til fremstilling af formylimidazoler